InsuCare Nepal | Your Health Matters — Right Medicine, Right Time
Diabetes is one of the growing public health concerns in Nepal. According to the International Diabetes Federation (IDF), approximately 1.26 million adults aged 20–79 were living with diabetes in Nepal in 2024.
For people managing diabetes, access to appropriate medicines, accurate product information and correct storage practices is an important part of maintaining their health.
Insulin is an essential medicine for people with type 1 diabetes and is also prescribed to some people with type 2 diabetes. However, insulin is available in different formulations, concentrations and delivery systems, making it important for patients to understand the differences.
At InsuCare Nepal Private Limited, we aim to improve access to healthcare products and reliable medicine information for pharmacies, hospitals, healthcare institutions and patients in Nepal.
In this guide, we explain the different types of insulin, common insulin delivery systems, safe storage practices and important precautions when handling diabetes medicines.
Insulin is a hormone produced by the pancreas that helps regulate blood glucose levels.
After eating, carbohydrates are broken down into glucose, which enters the bloodstream. Insulin helps glucose move into the body's cells, where it can be used for energy.
People with diabetes may not produce enough insulin or may not use insulin effectively.
Insulin treatment helps manage blood glucose and reduces the risk of complications associated with prolonged high blood sugar.
Insulin therapy may be required for:
People with type 1 diabetes, who require insulin replacement.
People with type 2 diabetes when other treatments do not provide adequate glucose control.
Certain individuals with diabetes during pregnancy, under medical supervision.
Patients requiring insulin during specific medical situations or hospital treatment.
The type and dose of insulin must always be determined by a qualified healthcare professional.
Insulin medicines are classified according to how quickly they begin working and how long their glucose-lowering effects continue.
Rapid-acting insulin begins working quickly and is commonly used to manage blood glucose increases associated with meals.
Examples include:
NovoRapid (Insulin Aspart)
Humalog (Insulin Lispro)
Apidra (Insulin Glulisine)
Fiasp (Faster-Acting Insulin Aspart)
These medicines are typically administered close to mealtimes, according to the specific product instructions and prescribed treatment schedule.
Short-acting human insulin, also called regular insulin, is another treatment option for managing blood glucose around meals.
Examples include:
Actrapid HM
Huminsulin Regular
Lupisulin R
Wosulin R
Regular human insulin generally requires administration earlier before a meal than rapid-acting insulin analogues.
Intermediate-acting insulin provides glucose-lowering activity over a longer period than short-acting insulin.
An example is NPH (Isophane) human insulin.
These formulations are often cloudy suspensions and generally require gentle mixing before use, following the manufacturer's instructions.
Long-acting insulin provides background insulin activity to help maintain blood glucose control between meals and overnight.
Examples include:
Lantus (Insulin Glargine)
Abasaglar (Insulin Glargine)
Tresiba (Insulin Degludec)
Levemir (Insulin Detemir)
The duration of action differs between products. They are not automatically interchangeable, and switching requires medical guidance.
Premixed insulin combines two insulin components that provide different patterns of glucose-lowering activity.
Common examples include:
Mixtard 30 HM: Contains 30% soluble human insulin and 70% isophane human insulin.
Humalog Mix50: Contains 50% insulin lispro and 50% insulin lispro protamine suspension.
NovoMix 50 Penfill: Contains 50% soluble insulin aspart and 50% protamine-crystallised insulin aspart.
Ryzodeg 70/30: Contains 70% insulin degludec and 30% insulin aspart.
Although these products combine insulin actions, their timing, duration and dosing requirements differ. Patients must never substitute one formulation for another without medical supervision.
Insulin medicines are supplied in different packaging and delivery formats.
Insulin cartridges are designed for use with compatible reusable insulin pens.
A cartridge commonly contains 3 ml of insulin, although its concentration and total units must always be checked.
Cartridges should only be used with manufacturer-approved compatible devices and must never be refilled unless specifically designed and authorized for that purpose.
Prefilled pens contain insulin within a disposable injection device.
They eliminate the need to load a separate cartridge and allow the patient to select a prescribed dose using the pen's dosing mechanism.
Examples include SoloStar, FlexPen, FlexTouch and KwikPen presentations.
Insulin vials contain injectable insulin that may be withdrawn using an appropriate insulin syringe.
Different vial concentrations exist, including 40 IU/ml and 100 IU/ml in some markets.
Using the wrong syringe for an insulin concentration can cause a serious dosing error.
Important: Always verify the product name, concentration, delivery device and prescribed dose before administering insulin.
Insulin is sensitive to temperature. Exposure to excessive heat, freezing conditions or direct sunlight may damage insulin and reduce its effectiveness.
Proper insulin storage is particularly important in Nepal, where temperatures and access to reliable refrigeration can vary between locations and seasons.
For most insulin products, the recommended storage conditions are:
Refrigerate between 2°C and 8°C.
Never allow insulin to freeze.
Keep insulin away from the freezer compartment.
Protect medicine from direct sunlight.
Maintain appropriate storage conditions during transportation.
Check the expiry date before use.
Storage instructions vary depending on the product.
Many insulin pens and cartridges can be stored at controlled room temperature for a limited period after opening. However, the permitted temperature and storage duration are product-specific.
Some products may have an in-use period of 28 days, while others have different limits.
Always follow the manufacturer-approved storage instructions for the specific insulin product.
During warmer months, it is important to protect insulin from excessive temperatures.
Avoid leaving insulin:
Inside parked vehicles.
Near windows exposed to direct sunlight.
Close to heaters or cooking equipment.
In locations where the temperature exceeds the product's recommended limit.
When transporting unopened insulin that requires refrigeration, use suitable temperature-controlled packaging. Prevent direct contact between the insulin and frozen cooling elements.
If you suspect that insulin has been exposed to damaging temperatures, consult a pharmacist or manufacturer before using it.
Insulin is an effective treatment when used correctly, but mistakes in administration or storage can cause serious health problems.
Follow these essential precautions:
Always use insulin prescribed by your doctor.
Check the insulin name and concentration before every injection.
Never change the prescribed dose without medical guidance.
Monitor blood glucose according to your treatment plan.
Follow manufacturer-approved instructions for preparing and injecting insulin.
Never share insulin pens, cartridges, needles or syringes.
Rotate injection sites as instructed by your healthcare professional.
Never use insulin that has frozen, expired or appears abnormal.
Dispose of used needles in an appropriate sharps container.
Patients should also understand how to recognize and respond to hypoglycaemia, including symptoms such as sweating, trembling, hunger, confusion and dizziness.
Severe hypoglycaemia can be life-threatening and requires urgent treatment.
Medicine quality depends not only on manufacturing but also on appropriate handling throughout the supply chain.
From suppliers to pharmacies and healthcare facilities, storage and transportation conditions play an important role in preserving pharmaceutical product quality.
This is especially important for temperature-sensitive medicines such as insulin.
The World Health Organization emphasizes appropriate storage, transport conditions and inventory management as important elements of a reliable medicine supply system.
For pharmacies, healthcare institutions and pharmaceutical distributors, good practices include:
Monitoring storage temperatures.
Checking expiry dates and batch information.
Following manufacturer storage instructions.
Maintaining accurate inventory records.
Protecting temperature-sensitive medicines during transportation.
Ensuring medicines are handled by appropriately trained personnel.
These practices help maintain medicine integrity and support safer healthcare delivery.
InsuCare Nepal Private Limited is a pharmaceutical distribution business based in Lalitpur, Nepal.
Our purpose is to help connect healthcare products with pharmacies, hospitals and medical institutions while supporting access to clear and reliable product information.
Through our website, we aim to make it easier for customers and healthcare professionals to explore medicine categories, understand product information and make informed enquiries.
Our product information includes details such as:
Medicine name and composition.
Product strength and presentation.
Intended medical uses.
Manufacturer information.
Important precautions.
Storage and handling instructions.
For prescription-only medicines, customers should always follow applicable prescription requirements and obtain professional medical guidance.
Visit www.insucarenepal.com to explore product information and enquire about insulin and other healthcare medicines.
For product-specific availability, pack sizes, prescription requirements and other enquiries, contact InsuCare Nepal through the official website.
Most unopened insulin products should be stored in a refrigerator between 2°C and 8°C. In-use storage instructions differ by brand and presentation, so always check the approved product label.
No. Insulin that has been frozen should not be used, even if it later thaws.
An insulin cartridge is inserted into a compatible reusable pen, while a prefilled pen comes with insulin already contained inside a disposable device.
Insulin brands and formulations may differ in their action, concentration and administration requirements. Any change should be supervised by a qualified healthcare professional.
You can explore insulin product information through InsuCare Nepal's website and consult a registered pharmacist or doctor for advice about the medicine prescribed to you.
Effective diabetes management involves more than taking medication. Understanding insulin formulations, safe administration techniques, appropriate storage conditions and regular blood glucose monitoring is essential.
Different insulin medicines serve different treatment purposes, and the correct product must be selected according to individual medical requirements.
At InsuCare Nepal, our focus is to support access to healthcare products and trustworthy medicine information.
Your Health Matters — Right Medicine, Right Time.
Explore healthcare products and product information at https://www.insucarenepal.com.
Medical Disclaimer: This article is intended for general educational purposes only. It does not provide personal medical advice and should not be used to select or change insulin treatment. Always consult a registered doctor or pharmacist before using prescription medicines.
